BCM
Biomark Capital Management Portfolio holdings
AUM
$8.91M
This Quarter Return
-2.35%
1 Year Return
+97.06%
3 Year Return
+113.74%
5 Year Return
–
10 Year Return
–
AUM
$77.9M
AUM Growth
+$77.9M
(+7.1%)
Cap. Flow
+$18.7M
Cap. Flow
% of AUM
24.05%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
$18.7M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 12.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
JUNO
1
DELISTED
Juno Therapeutics, Inc.
JUNO
| $68.5M | 87.91% |
2,205,926
+603,364
| +38% | +$18.7M |
|
2
ADMA Biologics
ADMA
$4.1B
| $9.3M | 11.94% |
1,433,304
| – | – |
|
|
MBVX
3
DELISTED
MABVAX THERAPEUTICS HLDGS INC
MBVX
| $119K | 0.15% |
197,641
| – | – |
|